gatifloxacin has been researched along with Central Nervous System Tuberculosis in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A new nanocarrier is developed for the passage of gatifloxacin through the blood-brain barrier to treat central nervous system tuberculosis." | 7.85 | Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis. ( Barcia, E; Fernández-Carballido, A; García-García, L; Marcianes, P; Montejo, C; Negro, S, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marcianes, P | 1 |
| Negro, S | 1 |
| García-García, L | 1 |
| Montejo, C | 1 |
| Barcia, E | 1 |
| Fernández-Carballido, A | 1 |
1 other study available for gatifloxacin and Central Nervous System Tuberculosis
| Article | Year |
|---|---|
Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis.
Topics: Animals; Cerebral Cortex; Chemistry, Pharmaceutical; Fluoroquinolones; Gatifloxacin; Male; Microscop | 2017 |